Author:
Robin Marie,Espérou Hélène,De Latour Régis Peffault,Petropoulou Anna D.,Xhaard Aliénor,Ribaud Patricia,Socié Gérard
Reference7 articles.
1. Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type;Bacigalupo;Bone Marrow Transplantation,2010
2. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study;Guardiola;Blood,1999
3. Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia;Kerbauy;Biology of Blood and Marrow Transplantation,2007
4. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation;Kroger;Blood,2009
5. Allogeneic hematopoietic stem cell transplantation (HSCT) as a curative therapy in primary and secondary myelofibrosis (MF): a 14-year period oligocentric French experience;Lissandre;Blood (Annual Meeting Abstracts),2008
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献